These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D. Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465 [Abstract] [Full Text] [Related]
8. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin. Uchiyama N, Ito K, Kawai K, Sakamoto F, Takaki M, Ito M. Am J Dermatopathol; 1998 Oct; 20(5):513-7. PubMed ID: 9790118 [Abstract] [Full Text] [Related]
15. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues]. Zheng YY, Chen G, Zhou XG, Jin Y, Xie JL, Zhang SH, Zhang YN. Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587 [Abstract] [Full Text] [Related]
16. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA. Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806 [Abstract] [Full Text] [Related]